The Effects of Uterine Fibroids on Pregnancy in Women
Launched by WENWEN WANG · Aug 26, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how uterine fibroids, which are non-cancerous growths in the uterus, might affect a woman's ability to get pregnant. Researchers want to understand if having fibroids makes it harder for women to conceive. The study is currently looking for women aged 20 to 50 who have been diagnosed with uterine fibroids and who may or may not be experiencing infertility. Participants must have complete medical records to help the researchers gather accurate information.
If you decide to participate, you will be part of a group that shares your experience with fibroids and fertility. Your health data will be analyzed to see if there's a link between the presence of fibroids and challenges in getting pregnant. It's important to note that women with serious infections, autoimmune diseases, or a history of certain cancers won’t be eligible for this study. The findings from this trial could help improve understanding of how fibroids affect fertility and guide better treatment options for women facing these issues.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Age: 20-50 years
- • 2. Diagnosed with uterine fibroids (by ultrasound or pathology) combined with infertile or non-infertile patients
- • 3. Complete clinical data.
- Exclusion Criteria:
- • 1. Severe infectious disease or rheumatic immune disease active stage
- • 2. Previous history of malignant tumors
- • 3. Incomplete clinical data.
About Wenwen Wang
Wenwen Wang is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic interventions. With a focus on rigorous study design and ethical standards, Wenwen Wang leads initiatives that encompass a wide range of therapeutic areas. The sponsor prioritizes collaboration with research institutions and healthcare professionals to ensure the integrity and efficacy of clinical trials. Through meticulous planning and execution, Wenwen Wang aims to contribute valuable insights to the scientific community and enhance the development of safe and effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Trial Officials
Shixuan Wang
Principal Investigator
Huazhong University of Science and Technology, Wuhan, Hubei, China, 430000
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported